Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Coventry Health Care, Inc.    

News SummaryMost relevantAll newsSector newsTweets

Coventry Health Care, Inc. : Insurer Coventry Health Care Extends Pact With Medco By 3 Years

share with twitter share with LinkedIn share with facebook
share via e-mail
02/08/2012 | 07:02pm CEST
   By Jon Kamp 

Health insurer Coventry Health Care Inc. (CVH) has extended its contracts with pharmacy-benefit manager Medco Health Solutions Inc. (MHS) by three years while renegotiating for some beneficial changes, Coventry disclosed Wednesday.

The Bethesda, Md., insurer didn't describe the changes in detail, but Chief Financial Officer Randy Giles cited "an improved cost structure" and terms that give Coventry more flexibility. The new deal went into effect Jan. 1 and runs through 2015 for Medicare customers and 2016 for commercial customers.

"Given that pharmacy spend represents nearly 20% of our medical expenditures, this is an important improvement to a critical part of our overall cost structure across our product portfolio," Giles said on Coventry's fourth-quarter earnings call.

The new deal also gives Medco some longer-term security following a year in which the pharmacy-benefit manager, or PBM, has endured some high-profile customer losses.

Giles declined to comment on specifics regarding the cost-structure impact, but said the changes were a key driver for Coventry's positioning of Medicare Part D prescription drug products for this year. The changes were also an important factor as Coventry prepares for insurance exchanges called for by the U.S. health-care overhaul law, Giles said.

The new deal allows Coventry to "adapt more easily to health care changes in the marketplace going forward," the CFO said. He called Medco a "critical partner" for Coventry.

PBMs handle drug benefits for corporate customers and health plans. Medco is awaiting anti-trust clearance for its planned deal with competitor Express Scripts Inc. (ESRX), which aims to buy Medco to create the industry's biggest PBM.

The Wall Street Journal reported Tuesday that a final Federal Trade Commission decision on the deal is not imminent according to people familiar with the matter, and that the companies and agency are talking about whether combined mail-order pharmacy and specialty pharmacy operations would harm competition.

The proposed consolidation has drawn sharp criticism from retail pharmacies and consumer groups. The PBMs, which have said they expect the deal to close in the first half this year, say joining forces would give them clout to negotiate larger drug discounts, lower health-care costs and improve patient care.

Medco shares recently traded down 0.8% to $60.13. Shares of Coventry, which reported lower-than-expected earnings for the fourth quarter due to a higher tax rate, were down 2.4% to $30.25.

-By Jon Kamp, Dow Jones Newswires; 617-654-6728; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
2013DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2013 COVENTRY HEALTH CARE, INC. : Coventry Health Care Reports First Quarter Earnings
2013DJAetna Raises Earnings Outlook; Shares At 5-Year Highs
2013DJAetna Earnings Slip on Charges; Raises Year View
2013DJAetna Earnings Slip on Charges; Raises Year View
2013DJAetna 1st-Quarter Net Falls 4.1% on Charges; Raises Year View
2013COVENTRY HEALTH CARE, INC. : quaterly earnings release
2013 COVENTRY HEALTH CARE, INC. : Coventry Health Care Schedules Release of First Qua..
2013 Insight - When options trading ahead of deals raises eyebrows
2013 COVENTRY HEALTH CARE, INC. : ex-dividend day
More news
Financials ($)
Sales 2013 14 376 M
EBIT 2013 -
Net income 2013 -
Debt 2013 -
Yield 2013 -
P/E ratio 2013 -
P/E ratio 2014
Capi. / Sales 2013 0,47x
Capi. / Sales 2014 0,40x
Capitalization 6 733 M
Income Statement Evolution
Allen F. Wise Executive Chairman & Chief Executive Officer
Tim Thaddeus Weglicki Independent Director
Lawrence N. Kugelman Independent Director
Matthew D. Eyles Vice President-Public Affairs & Policy
James E. McGarry Manager
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC31.18%53 468
ANTHEM INC29.78%48 578
HUMANA INC22.18%35 905